Results 131 to 140 of about 4,963,319 (355)

Frequency of Chronic Hepatitis in 238 Cases Autopsied at the Forensic Medicine of Hamadan Province in 1997-98

open access: yesپزشکی بالینی ابن سینا, 2001
Viral hepatitis is one of the most prevalent diseases  world  wide and  is    the commonest cause of cirrhosis and  liver cancer. Chronic  viral hepatitis    can  be caused by, HBV, HCV or HDV  superimposed on HBV, these viruses    may infect high ...
Mahmoud Sattari
doaj  

Potential intravenous drug interactions in intensive care

open access: yesRevista da Escola de Enfermagem da USP
OBJECTIVE To analyze potential intravenous drug interactions, and their level of severity associated with the administration of these drugs based on the prescriptions of an intensive care unit.
Maiara Benevides Moreira   +3 more
doaj   +1 more source

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis. [PDF]

open access: yes, 2013
ObjectiveEtrolizumab (rhuMAb β7, anti-β7, PRO145223) is a humanised monoclonal antibody targeting the β7 subunit of the heterodimeric integrins α4β7 and αEβ7, which are implicated in leucocyte migration and retention in ulcerative colitis (UC).
Baumgart, Daniel C   +16 more
core  

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

open access: yesArthritis Care &Research, Accepted Article.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti   +19 more
wiley   +1 more source

Intravenous iron reactions: Insights from an allergy and immunology perspective

open access: yesJournal of Allergy and Clinical Immunology: Global
Background: Diagnosis and management of intravenous iron reactions is often challenging, as skin testing has unproven utility and most reactions are non–IgE-mediated.
Jordon Jaggers, MD   +3 more
doaj   +1 more source

Reaching high-risk patient populations through emergency department opt-out HIV testing: A retrospective chart review [PDF]

open access: yes, 2017
Specific Aims and Hypotheses: This study aimed to identify socioeconomic (SE), sexual, and other risk factors (RFs), among patients diagnosed with HIV infection through an emergency department-based opt-out HIV screening program, and to examine trends ...
Boyce, BA, Tyler G.   +1 more
core   +1 more source

Performance Characteristics of Anti‐Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

open access: yesArthritis Care &Research, Accepted Article.
Background Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti‐collagen II (anti‐Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick   +6 more
wiley   +1 more source

The Advent Of Cytomegalovirus Infection In HIV Infected Patients: A review [PDF]

open access: yes, 2004
Cytomegalovirus is considered as one among the long list of latent infections in humans that although normally controlled by the cellular immune response, gets activated after HIV infection takes its role on infecting the T4 lymphocytes. Clinical disease
Kirubakaran Isaac, Dr Sundar
core   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

open access: yesArthritis Care &Research, Accepted Article.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy